Curr Opin Urol

• 

  Publication Venue For

  • New devices for kidney stone management..  30:144-148. 2020
  • Management of extraretroperitoneal masses in germ cell tumor..  29:33-41. 2019
  • Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement..  28:506-511. 2018
  • Obesity and metabolic stone disease..  27:422-427. 2017
  • Alternative payment models and urology..  27:360-365. 2017
  • High-intensity focused ultrasound for focal therapy: reality or pitfall?.  27:138-148. 2017
  • Role of salvage lymph node dissection in prostate cancer..  26:581-589. 2016
  • Rectourethral fistulas in the cancer survivor..  24:382-388. 2014
  • Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature..  24:75-80. 2014
  • Molecular Pathology of Prostate Cancer Revealed by Next Generation Sequencing: Opportunities for Genome-Based Personalized Therapy.  23:189-193. 2013
  • Risk reduction strategy for radiation exposure during percutaneous nephrolithotomy..  22:139-143. 2012
  • Modern applications of ureteroscopy for intrarenal stone disease..  21:141-144. 2011
  • The impact of new methods of imaging on radiation dosage delivered to patients..  20:163-168. 2010
  • Focal therapy for prostate cancer: pathologic basis..  19:161-167. 2009
  • Nerve-sparing focal cryoablation of prostate cancer..  19:182-187. 2009
  • Prostate cancer: the new landscape..  19:154-160. 2009
  • Computed tomography urography, three-dimensional computed tomography and virtual endoscopy..  12:137-142. 2002
  • Modern applications of ureteroscopy for intrarenal stone disease 2011